Recent News

• 06.02.2026 - BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine
• 05.28.2026 - BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors
• 05.19.2026 - BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market

Recent Filings

• 06.03.2026 - 3 Initial statement of beneficial ownership of securities
• 06.02.2026 - EFFECT Notice of Effectiveness
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.28.2026 - EX-99.1 EX-99.1
• 05.28.2026 - 8-K Current report
• 05.21.2026 - S-1 General form for registration of securities under the Securities Act of 1933